September’s top five cataract surgery articles
September’s top cataract surgery articles involve postoperative inflammation therapies and cataract surgery in patients with uveitic glaucoma.
Netildex gel meets primary endpoint
A phase 3 trial demonstrated noninferiority of Netildex gel twice daily compared with solution four times daily to treat ocular inflammation after cataract surgery. Read more.
First pediatric patients dosed in phase 3 Dextenza trial
Ocular Therapeutix has dosed the first patients in a phase 3 clinical trial of Dextenza for postoperative ocular inflammation and pain in children after cataract surgery. Read more.
Phantoms of the OR: Premium surgeons always rise to the occasion
I feel at times we as premium surgeons are our own phantoms, working diligently behind the scenes to find better ways to help our patient outcomes. Read more.
Triamcinolone-moxifloxacin stabilizes macular thickness after cataract surgery in DR
An intravitreal triamcinolone acetonide-moxifloxacin injection during cataract surgery maintained postoperative central macular thickness stability in patients with preexisting diabetic retinopathy. Read more.
Cataract surgery challenging in eyes with uveitic glaucoma
Cataract surgery in eyes with small pupils is a challenge, and having a history of uveitis makes it even more so due to the iris synechiae that tend to form. Read more.